Facial disfigurement: is it in the eye of the beholder? A study in patients with Graves' ophthalmopathy

被引:23
|
作者
Terwee, CB
Dekker, FW
Bonsel, GJ
Heisterkamp, SH
Prummel, MF
Baldeschi, L
Wiersinga, WM
机构
[1] VU Med Ctr, Inst Res Extramural Med, EMGO Inst, NL-1081 BT Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Orbital Ctr, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands
[6] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RA Leiden, Netherlands
关键词
D O I
10.1046/j.1365-2265.2003.01695.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The importance of facial disfigurement in many diseases necessitates a reliable and valid measure of disfigurement severity for clinical studies. The hypothesis is that a universal concept of disfigurement exists and can be measured in a reliable way. The objectives of this study were to investigate if persons, in particular patients and physicians, can agree on facial disfigurement severity; and to determine the relative contribution of predefined clinical characteristics of patients with Graves' ophthalmopathy (GO) to the overall rating of facial disfigurement severity. DESIGN A panel study was carried out in four different panels, each consisting of four members. PATIENTS We randomly selected 100 slide pairs of GO patients from four available study populations, involving mild, moderate and severe GO patients (mean age 49 years, 76% female) who were treated with either radiotherapy, sham-irradiation, prednisone or orbital decompression. MEASUREMENTS All panel members individually scored the disfigurement severity of 100 GO patients shown on standardized slides on a Visual Analog Scale. In total, 1600 ratings were collected. We calculated within- and between-panel agreement of disfigurement severity and identified determinants of disfigurement. RESULTS Agreement within a panel varied from 0.65 to 0.79 and was highest within the panel of ophthalmologists. Between-panel agreement was 0.67 and was highest between ophthalmologists and laypersons. Compared with the global average, patients overrated and endocrinologists underrated disfigurement severity. Female panellists rated the patients, on average, more disfigured than male panellists. Important determinants of disfigurement were eyelid retraction, severe eyelid swelling and proptosis. Their relative importance was consistent across panels and in contrast to current measures of GO severity. CONCLUSION Facial disfigurement severity can be measured in a reliable way using panels of panellists. Except for some systematic differences between panellists, facial disfigurement does not seem to be in the eye of the beholder.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 50 条
  • [21] SCARRED - CONTRIBUTION TO STUDY OF FACIAL DISFIGUREMENT
    NIEDERLAND, WG
    PSYCHOANALYTIC QUARTERLY, 1975, 44 (03): : 450 - 459
  • [22] Brain asymmetry and facial attractiveness: Facial beauty is not simply in the eye of the beholder
    Chen, AC
    German, C
    Zaidel, DW
    NEUROPSYCHOLOGIA, 1997, 35 (04) : 471 - 476
  • [23] SQUINT SURGERY IN PATIENTS WITH GRAVES OPHTHALMOPATHY
    WENNIGERPRICK, LJJMMD
    VANMOURIKNOORDENBOS, AM
    KOORNNEEF, L
    DOCUMENTA OPHTHALMOLOGICA, 1986, 61 (3-4) : 219 - 221
  • [24] OPHTHALMOPATHIC IMMUNOGLOBULIN IN PATIENTS WITH GRAVES OPHTHALMOPATHY
    ATKINSON, S
    HOLCOMBE, M
    KENDALLTAYLOR, P
    LANCET, 1984, 2 (8399): : 374 - 376
  • [25] Choroidal Thickness in Patients with Graves' Ophthalmopathy
    Caliskan, Sinan
    Acar, Mutlu
    Gurdal, Canan
    CURRENT EYE RESEARCH, 2017, 42 (03) : 484 - 490
  • [26] Graves' thyroid ophthalmopathy in Ethiopian patients
    Teshome, T
    Seyoum, B
    ETHIOPIAN MEDICAL JOURNAL, 2001, 39 (01) : 1 - 8
  • [27] Are patients with Graves' Ophthalmopathy at risk for hyperglycemia?
    Kikani, Bijal
    Wai, Karen
    Rahimy, Ehsan
    Dosiou, Chrysoula
    Kim, Sun H.
    Mruthyunjaya, Prithvi
    Kossler, Andrea
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [28] GRAVES OPHTHALMOPATHY EVALUATED BY INFRARED EYE-MOVEMENT RECORDINGS
    FELDON, SE
    UNSOLD, R
    ARCHIVES OF OPHTHALMOLOGY, 1982, 100 (02) : 324 - 328
  • [29] Eye muscle antibodies in Graves' ophthalmopathy: Pathogenic or secondary epiphenomenon?
    Mizokami, T
    Salvi, M
    Wall, JR
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2004, 27 (03) : 221 - 229
  • [30] Eye muscle antibodies in Graves’ ophthalmopathy: Pathogenic or secondary epiphenomenon?
    T. Mizokami
    M. Salvi
    Jack R. Wall
    Journal of Endocrinological Investigation, 2004, 27 : 221 - 229